NASDAQ

In this analysis, we meticulously examine the recent performance of the Nasdaq 100 and US 500 indices to gauge their strength and determine whether the current trend can be sustained. By evaluating key indicators and price action, we aim to provide insightful guidance to traders and investors, equipping them with…

Bearish Bets Against S&P 500 Are Surging, Despite Love for Big Tech This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints…

BOCA RATON, FL / ACCESSWIRE / June 2, 2023 / Greenlane Holdings, Inc. (NASDAQ:GNLN) ("Greenlane"), one of the largest global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced that it will effect a one-for-10 reverse stock split ("reverse split") of its Class A common stock,…

CLEARWATER, FL / ACCESSWIRE / June 2, 2023 / Fortune Rise Acquisition Corporation (NASDAQ:FRLA) ("FRLA" or the "Company") today announced that its sponsor, Fortune Rise Sponsor LLC (the "Sponsor"), has requested a one-month extension to complete its initial business combination. Per the terms of the Company's governing documents, the Sponsor…

1 minute read       Service Properties Trust June, 2 2023   Guestroom at the Nautilus Hotel in South Beach Miami Service Properties Trust (Nasdaq: SVC) announced today that it has acquired the 250-room Nautilus Hotel located at 1825 Collins Avenue, Miami Beach, FL for $165.4 million, or approximately $661,600 per key.…

Fintel reports that on June 1, 2023, HC Wainwright & Co. reiterated coverage of TG Therapeutics (NASDAQ:TGTX) with a Buy recommendation. Analyst Price Forecast Suggests 15.15% Upside As of June 1, 2023, the average one-year price target for TG Therapeutics is 30.66. The forecasts range from a low of 6.06…

We use cookies and data to Deliver and maintain Google servicesTrack outages and protect against spam, fraud, and abuseMeasure audience engagement and site statistics to understand how our services are used and enhance the quality of those servicesIf you choose to “Accept all,” we will also use cookies and data…

SAN JOSE, CA / ACCESSWIRE / May 31, 2023 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company") today announced that it has entered into a securities purchase agreement with an institutional investor (the "Investor") in connection with a registered direct offering, which was priced at-the-market under Nasdaq rules, of an…

MCLEAN, VA / ACCESSWIRE / May 31, 2023 / Gladstone Capital Corporation (Nasdaq:GLAD) (the "Company") today announced that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission ("SEC") for a continuous public offering of up to 6,000,000 shares (the "Offering") of its newly-designated 6.25% Series A…

Fintel reports that on May 31, 2023, Piper Sandler upgraded their outlook for Akebia Therapeutics (NASDAQ:AKBA) from Neutral to Overweight . Analyst Price Forecast Suggests 112.81% Upside As of May 11, 2023, the average one-year price target for Akebia Therapeutics is 2.04. The forecasts range from a low of 2.02…